Crescent Biopharma, Inc. (CBIO)

Last Closing Price: 12.40 (2026-11-18)

Beginning Cash (Quarterly)

Beginning Cash: The amount of cash reported by the company on its previous statement.

Crescent Biopharma, Inc. (CBIO) had Beginning Cash of $213.30M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$3.12M
$-37.73M
--
$3.12M
$43.02M
$-39.91M
$2.18M
$-37.73M
$-37.73M
$-37.73M
$-37.73M
$-37.73M
$-37.73M
$-39.91M
$-39.84M
39.06M
39.06M
$-0.90
$-0.90
Balance Sheet Financials
$295.21M
$0.81M
$4.29M
$299.50M
$23.49M
--
$1.73M
$25.22M
$270.28M
$274.28M
$274.28M
38.18M
Cash Flow Statement Financials
$-55.34M
$-6.39M
$138.00M
Beginning Cash
$213.30M
$289.58M
$76.28M
$12.30M
--
--
Fundamental Metrics & Ratios
12.57
--
--
--
--
100.00%
-1280.30%
-1280.30%
--
-1210.33%
-1210.33%
$-53.73M
--
--
--
0.01
--
--
--
-13.96%
-13.75%
-12.60%
-13.75%
$7.18
$-1.38
$-1.42